Form 4 · Filed May 19, 2026, 12:11 PM UTC
ARTV/Artiva Biotherapeutics, Inc.
Miralles Gines Diego — President & Head of R&D
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 18, 2026 | A | other | 77,500 | $0 | — | 77,500 |
| May 18, 2026 | A | other | 232,500 | — | — | 232,500 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-229727